细胞外体积分数在肿瘤相关领域中的应用进展
Advances in the Application of Extracellular Volume Fraction in Tumor-Related Fields
摘要: 恶性肿瘤(癌症)是威胁人类健康的重要原因之一,全面的了解肿瘤生物学行为,明确肿瘤的发生发展机制,有利于我们制定全面的战略和措施应对癌症带来的日益增长的死亡威胁。细胞外基质(extracellular matrix, ECM)在肿瘤的生物化学、生物力学、结构组成和分布上发生改变,它参与促进肿瘤细胞的生长、侵袭、转移和血管生成,而且抵抗细胞死亡和药物扩散。细胞外体积分数(Extracellular volume fraction, ECV)可以量化ECM,基于影像学检查的ECV分数与组织病理上的ECV具有较高的一致性,具有无创、定量、可重复等优点,在肿瘤相关预测因子、组织病理分级分化、复发转移及疗效评估等方面广泛应用,本文对ECV在肿瘤相关领域的应用进行了阐述和总结。
Abstract: Malignant tumors (cancer) are one of the most important causes of threats to human health. A comprehensive understanding of tumor biological behavior and clarification of the mechanisms of tumor development are beneficial for us to develop comprehensive strategies and measures to deal with the increasing threat of death from cancer. Extracellular matrix (ECM) is altered in the biochemistry, biomechanics, structural composition and distribution of tumors, and it is involved in promoting tumor cell growth, invasion, metastasis and angiogenesis, and it resists cell death and drug diffusion. Extracellular volume fraction (ECV) can quantify ECM, and ECV fraction based on imaging examination has high consistency with ECV on histopathology, which has the advantages of non-invasive, quantitative and reproducible, and is widely used in tumor-related predictors, histopathological grading and differentiation, recurrence and metastasis, and efficacy assessment, etc. In this paper, the application of ECV in tumor-related fields is described and summarized.
文章引用:徐阳, 郭大静. 细胞外体积分数在肿瘤相关领域中的应用进展[J]. 临床医学进展, 2023, 13(4): 6176-6181. https://doi.org/10.12677/ACM.2023.134870

参考文献

[1] Zheng, R., Zhang, S., Zeng, H., et al. (2022) Cancer Incidence and Mortality in China, 2016. Journal of the National Cancer Center, 2, 1-9. [Google Scholar] [CrossRef] [PubMed]
[2] Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30. [Google Scholar] [CrossRef] [PubMed]
[3] Cox, T.R. (2021) The Matrix in Cancer. Nature Reviews Cancer, 21, 217-238. [Google Scholar] [CrossRef] [PubMed]
[4] Ulyte, A., Katsaros, V.K., Liouta, E., et al. (2016) Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Perfusion Parameters for High-Grade Glioma Patients. Neu-roradiology, 58, 1197-1208. [Google Scholar] [CrossRef] [PubMed]
[5] He, Y., Liu, T., Dai, S., et al. (2021) Tumor-Associated Extra-cellular Matrix: How to Be a Potential Aide to Anti-Tumor Immunotherapy? Frontiers in Cell and Developmental Bi-ology, 9, Article ID: 739161. [Google Scholar] [CrossRef] [PubMed]
[6] Iwaya, H., Fukukura, Y., Hashimoto, S., et al. (2021) Prognostic Significance of Extracellular Volume Fraction with Equilibrium Contrast-Enhanced Computed Tomography for Pancre-atic Neuroendocrine Neoplasms. Pancreatology, 21, 779-786. [Google Scholar] [CrossRef] [PubMed]
[7] 王荣锟. 基于CT的细胞外体积分数与肾透明细胞癌病理分级的相关性研究[D]: [硕士学位论文]. 长春: 吉林大学, 2021.
[8] 邵瑞丽. 基于CT的细胞外体积分数对结肠癌肝转移、淋巴结转移的预测研究[D]: [硕士学位论文]. 长春: 吉林大学, 2020.
[9] Guo, S.L., Su, L.N., Zhai, Y.N., et al. (2017) The Clinical Value of Hepatic Extracellular Volume Fraction Using Routine Multiphasic Contrast-Enhanced Liver CT for Staging Liver Fibrosis. Clinical Radiology, 72, 242-246. [Google Scholar] [CrossRef] [PubMed]
[10] Luetkens, J.A., Klein, S., Träber, F., et al. (2018) Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results. Radiology, 288, 748-754. [Google Scholar] [CrossRef] [PubMed]
[11] Fukukura, Y., Kumagae, Y., Higashi, R., et al. (2019) Extracellular Volume Fraction Determined by Equilibrium Contrast-Enhanced Multidetector Computed Tomography as a Prognostic Factor in Unresectable Pancreatic Adenocarcinoma Treated with Chemotherapy. European Radiology, 29, 353-361. [Google Scholar] [CrossRef] [PubMed]
[12] Nishimuta, Y., Tsurumaru, D., Kai, S., et al. (2023) Extracellular Volume Fraction Determined by Equilibrium Contrast-Enhanced Computed Tomography: Correlation with Histopathological Findings in Gastric Cancer. Japanese Journal of Radiology. [Google Scholar] [CrossRef] [PubMed]
[13] Bandula, S., White, S.K., Flett, A.S., et al. (2013) Measurement of Myocardial Extracellular Volume Fraction by Using Equilibrium Contrast-Enhanced CT: Validation against Histologic Findings. Radiology, 269, 396-403. [Google Scholar] [CrossRef
[14] Bandula, S., Punwani, S., Rosenberg, W.M., et al. (2015) Equilib-rium Contrast-Enhanced CT Imaging to Evaluate Hepatic Fibrosis: Initial Validation by Comparison with Histopathologic Sampling. Radiology, 275, 136-143. [Google Scholar] [CrossRef] [PubMed]
[15] Bak, S., Kim, J.E., Bae, K., et al. (2020) Quantification of Liver Extracellular Volume Using Dual-Energy CT: Utility for Prediction of Liver-Related Events in Cirrhosis. European Radiology, 30, 5317-5326. [Google Scholar] [CrossRef] [PubMed]
[16] Adams, L.C., Jurmeister, P., Ralla, B., et al. (2019) Assessment of the Extracellular Volume Fraction for the Grading of Clear Cell Renal Cell Carcinoma: First Results and Histopathological Findings. European Radiology, 29, 5832-5843. [Google Scholar] [CrossRef] [PubMed]
[17] Lee, H.J., Im, D.J., Youn, J.C., et al. (2016) Myocardial Extra-cellular Volume Fraction with Dual-Energy Equilibrium Contrast-enhanced Cardiac CT in Nonischemic Cardiomyopathy: A Prospective Comparison with Cardiac MR Imaging. Radiology, 280, 49-57. [Google Scholar] [CrossRef] [PubMed]
[18] Takumi, K., Nagano, H., Myogasako, T., et al. (2023) Feasibility of Iodine Concentration and Extracellular Volume Fraction Measurement Derived from the Equilibrium Phase Du-al-Energy CT for Differentiating Thymic Epithelial Tumors. Japanese Journal of Radiology, 41, 45-53. [Google Scholar] [CrossRef] [PubMed]
[19] Nathanson, S.D. (2003) Insights into the Mechanisms of Lymph Node Metastasis. Cancer, 98, 413-423. [Google Scholar] [CrossRef] [PubMed]
[20] Ji, R.C. (2006) Lymphatic Endothelial Cells, Tumor Lymphangiogenesis and Metastasis: New Insights into Intratumoral and Peritumoral Lymphatics. Cancer Metastasis Reviews, 25, 677-694. [Google Scholar] [CrossRef] [PubMed]
[21] Zhou, Y., Su, G.Y., Hu, H., et al. (2020) Radiomics Analysis of Dual-Energy CT-Derived Iodine Maps for Diagnosing Metastatic Cervical Lymph Nodes in Patients with Papillary Thyroid Cancer. European Radiology, 30, 6251-6262. [Google Scholar] [CrossRef] [PubMed]
[22] Chang, C.C., Lin, C.Y., Chu, C.Y., et al. (2020) Extracellular Volume Fraction Measurement Correlates with Lymphocyte Abundance in Thymic Epithelial Tumors. Cancer Imaging, 20, 71. [Google Scholar] [CrossRef] [PubMed]
[23] Bali, M.A., Metens, T., Denolin, V., et al. (2011) Tumoral and Nontumoral Pancreas: Correlation between Quantitative Dynamic Contrast-Enhanced MR Imaging and Histopathologic Parameters. Radiology, 261, 456-466. [Google Scholar] [CrossRef] [PubMed]
[24] Couvelard, A., O’toole, D., Leek, R., et al. (2005) Expression of Hypoxia-Inducible Factors Is Correlated with the Presence of a Fibrotic Focus and Angiogenesis in Pancreatic Ductal Adenocarcinomas. Histopathology, 46, 668-676. [Google Scholar] [CrossRef] [PubMed]
[25] Luo, Y., Liu, L., Liu, D., et al. (2022) Extracellular Volume Fraction Determined by Equilibrium Contrast-Enhanced CT for the Prediction of the Pathological Complete Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. European Radiology. [Google Scholar] [CrossRef] [PubMed]
[26] Alabed, S., Saunders, L., Garg, P., et al. (2021) Myocardial T1-Mapping and Extracellular Volume in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. Magnetic Resonance Imaging, 79, 66-75. [Google Scholar] [CrossRef] [PubMed]
[27] Yoon, J.H., Lee, J.M., Klotz, E., et al. (2015) Estimation of Hepatic Extracellular Volume Fraction Using Multiphasic Liver Computed Tomography for Hepatic Fibrosis Grading. Investigative Radiology, 50, 290-296. [Google Scholar] [CrossRef
[28] Sofue, K., Ueshima, E., Masuda, A., et al. (2022) Estimation of Pancreatic Fibrosis and Prediction of Postoperative Pancreatic Fistula Using Extracellular Volume Fraction in Multiphasic Contrast-Enhanced CT. European Radiology, 32, 1770-1780. [Google Scholar] [CrossRef] [PubMed]
[29] Engblom, H., Kanski, M., Kopic, S., et al. (2018) Importance of Standardizing Timing of Hematocrit Measurement When Using Cardiovascular Magnetic Resonance to Calculate Myocardial Extracellular Volume (ECV) Based on Pre- and Post-Contrast T1 Mapping. Journal of Cardiovascular Magnetic Resonance, 20, 46. [Google Scholar] [CrossRef] [PubMed]
[30] Shinagawa, Y., Sakamoto, K., Sato, K., et al. (2018) Usefulness of New Subtraction Algorithm in Estimating Degree of Liver Fibrosis by Calculating Extracellular Volume Fraction Obtained from Routine Liver CT Protocol Equilibrium Phase Data: Preliminary Experience. European Journal of Ra-diology, 103, 99-104. [Google Scholar] [CrossRef] [PubMed]